Abstract:There are some evidences that pituitary tumors may be sensitive to the anti-proliferative effects of mammalian target of rapamycin (mTOR) inhibitors, while the mechanism and effects remains unclear, it is necessary to find if a specific mTOR inhibition, including the blocking of both mTOR function and expression, generate any effects on pituitary adenoma cells. The object of this study was to examine if specific inhibition of mTOR induced anti-proliferative effect and decreased the GH and PRL hormones secretion in GH3 and MtT/E pituitary adenoma cells by using a kind of mTOR shRNA lentiviral vector. The in vitro experiments results showed mTOR shRNA transfection robustly reduced the GH3 and MtT/E cells viability in all durations (1–6 days) we performed, also specifically decreased both GH and PRL hormones external secretion in GH3 cells. Further results suggested that specific inhibition of mTOR decreased the hormones secretion through anti-proliferation effects on GH3 cells and reducing the hormones synthesis, but not through affecting the process of hormones secretion. Then we used phosphatidic acid (PA), a kind of mTOR activator, to promote the cell proliferation and GH and PRL hormones secretion in GH3 cells while the effects were blocked by mTOR shRNA transfection. In addition, we examined in vitro effects of PA treatment and mTOR shRNA gene transfection on major proteins expressed in the mTOR pathway in GH3 cells, and confirmed that PA treatment significant increased the protein levels of pmTOR, pS6 K and p4EBP1 in the scramble shRNA group, while the increase of protein levels was blocked by mTOR shRNA gene transfection. Moreover, mTOR shRNA gene transfection definitely inhibited the expression of mTOR and reduced the expression of pmTOR, pS6K and p4EBP1 in either PA or no PA treatment groups. These findings indicated that specific inhibition of mTOR pathway induced anti-proliferative effect and decreased the GH and PRL hormones secretion in cultured pituitary adenoma cells, which may be a novel promising and potential treatment modality for patients with secreting or non-secreting pituitary adenomas.

[Inhibitory effect of adenovirus-mediated D2S gene plus bromocriptine therapy on primary cultures of human non-functioning pituitary adenoma cells]

Adenovirus-mediated gene transfer of human D2S combined with bromocriptine inhibits proliferation of GH3 rat anterior pituitary cells

Dopamine receptor D2S gene transfer improves the sensitivity of GH3 rat pituitary adenoma cells to bromocriptine

Differential effects of nerve growth factor on expression of dopamine 2 receptor subtypes in GH3 rat pituitary tumor cells

Adenovirus-mediated Inhibitor Kappab Gene Transfer Improves the Chemosensitivity to Anticancer Drugs in Human Lung Cancer in Vitro and in Vivo.

Induction of apoptosis by oridonin in nonfunctioning pituitary adenoma cells

Inhibition of Skp2 Sensitizes Bromocriptine-Induced Apoptosis in Human Prolactinoma Cells

[Inhibitory Effects of ODC and AdoMetDC Bi-Antisense Virus on the Growth and Invasion of Lung Cancer Cell A-549].

Combined Treatment with Artesunate and Bromocriptine Has Synergistic Anticancer Effects in Pituitary Adenoma Cell Lines.

Effects of L-dopa on Cells Expressing D2 Receptors and Level of Dopamine Transmitter in Hemiparkinsonian Rats

Medical Management of Pituitary Adenomas:A Study of Ultrastructural Changes and Receptor Expressions

Dddr-47. Targeting Htr2B Suppresses Non-Functioning Pituitary Adenoma Growth And Sensitizes Cabergoline Treatment Viainhibiting Gαq/Plc/Pkcγ/Stat3 Axis

Therapeutic Effects of Adenovirus-Mediated CD and NIS Expression Combined with Na131I/5-FC on Human Thyroid Cancer.

Prevention of dopaminergic neuron death by adeno-associated virus vector-mediated GDNF gene transfer in rat mesencephalic cells in vitro.

[Therapeutic Effect of Adenovirus-Mediated Apoptin Gene Transfer Combined with ADM and CDDP on Hepatocellular Carcinoma in Mice].

Identification of driver genes and key pathways of non-functional pituitary adenomas predicts the therapeutic effect of STO-609

Specific inhibition of mTOR pathway induces anti-proliferative effect and decreases the hormone secretion in cultured pituitary adenoma cells

Inhibition Effect of Adenovirus-mediated PTEN Gene on NCI-H446 Cell Growth

Protective Effects of Intracerebral Adenoviral-Mediated GDNF Gene Transfer in a Rat Model of Parkinson's Disease

Targeting HTR2B Suppresses Nonfunctioning Pituitary Adenoma Growth and Sensitizes Cabergoline Treatment Via Inhibiting Gαq/PLC/PKCγ/STAT3 Axis.

Brusatol Inhibits Tumor Growth and Increases the Efficacy of Cabergoline Against Pituitary Adenomas